INTRODUCTION: Hybridoma technology is a method for producing large numbers of identical antibodies (also called monoclonal antibodies ). This process starts by injecting a mouse (or other mammal) with an antigen that provokes an immune response. A type of white blood cell, the B cell, produces antibodies that bind to the injected antigen. These antibody producing B-cells are then harvested from the mouse and, in turn, fused with immortal B cell cancer cells, a myeloma , to produce a hybrid cell line called a hybridoma , which has both the antibody-
EKPENYONG, J. (2020). Hybridoma Technology. Afribary. Retrieved from https://tracking.afribary.com/works/hybridoma
EKPENYONG, JOSEPH "Hybridoma Technology" Afribary. Afribary, 19 Oct. 2020, https://tracking.afribary.com/works/hybridoma. Accessed 13 Nov. 2024.
EKPENYONG, JOSEPH . "Hybridoma Technology". Afribary, Afribary, 19 Oct. 2020. Web. 13 Nov. 2024. < https://tracking.afribary.com/works/hybridoma >.
EKPENYONG, JOSEPH . "Hybridoma Technology" Afribary (2020). Accessed November 13, 2024. https://tracking.afribary.com/works/hybridoma